Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded Healthcare sector company. As of September 1, 2026, AMPH trades at $22.55 with a market cap of $936.26M and a P/E ratio of 12.90. AMPH moved +0.07% today. Year to date, AMPH is -15.87%; over the trailing twelve months it is -26.42%. Its 52-week range spans $16.65 to $39.01. Analyst consensus is neutral with an average price target of $22.17. Rallies surfaces AMPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AMPH, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $22.55 |
| Market Cap | $936.26M |
| P/E Ratio | 12.90 |
| EPS | $1.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.01 |
| 52-Week Low | $16.65 |
| Volume | 32 |
| Avg Volume | 0 |
| Revenue (TTM) | $730.02M |
| Net Income | $78.55M |
| Gross Margin | 47.69% |
6 analysts cover AMPH: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $22.17.